Stocksigma LogoStocksigma Logo

Gujarat Themis Biosyn Reports Nil Deviation in QIP Fund Utilization

Gujarat Themis Biosyn reported nil deviation in the utilization of ₹75,000.00 lakh raised via its QIP completed on 28th Aug'26, as per India Ratings

Gujarat Themis Biosyn Reports Nil Deviation in QIP Fund Utilization

Gujarat Themis Biosyn Ltd · Others (Uncategorized) · 14 Nov 2026, 11:31 pm

Gujarat Themis Biosyn Reports Nil Deviation in QIP Fund Utilization Gujarat Themis Biosyn reported nil deviation in the utilization of ₹75,000.00 lakh raised via its QIP completed on 28th Aug'26, as per India Ratings & Research's monitoring report for the quarter ended 30th Sep'26. The company utilized ₹72,700.00 lakh toward inorganic growth via subsidiary Themis Biosyn Japan and ₹213.93 lakh for issue expenses, totaling ₹72,913.93 lakh in total utilization. The unutilized balance of ₹2,086.07 lakh remains deposited across bank escrow and operational accounts, earmarked for remaining issue expenses and general corporate purposes.

Original exchange filing (PDF)

More announcements from Gujarat Themis Biosyn Ltd

All Gujarat Themis Biosyn Ltd announcements